BI
TYRA icon

BVF Inc’s Tyra Biosciences TYRA Stock Holding History

BVF Inc’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$75.7M Sell
1,976,196
-151,469
-7% -$4.9M 2.41% 16
2025
Q4 		$55.9M Sell
2,127,665
-1,522,129
-42% -$28M 1.88% 19
2025
Q3 		$51.1M Sell
3,649,794
-294,400
-7% -$3.36M 2.07% 19
2025
Q2 		$37.7M Hold
3,944,194
– – 1.35% 17
2025
Q1 		$36.7M Hold
3,944,194
– – 1.5% 14
2024
Q4 		$54.8M Sell
3,944,194
-717,000
-15% -$13M 1.86% 12
2024
Q3 		$110M Hold
4,661,194
– – 3.21% 5
2024
Q2 		$74.5M Hold
4,661,194
– – 2.09% 18
2024
Q1 		$76.4M Buy
4,661,194
+1,921,599
+70% +$31.5M 2.1% 14
2023
Q4 		$37.9M Hold
2,739,595
– – 0.95% 27
2023
Q3 		$37.7M Hold
2,739,595
– – 1.02% 23
2023
Q2 		$46.7M Sell
2,739,595
-500,000
-15% -$7.25M 1.3% 22
2023
Q1 		$52.1M Buy
3,239,595
+767,268
+31% +$9.13M 1.9% 17
2022
Q4 		$18.8M Hold
2,472,327
– – 0.79% 39
2022
Q3 		$21.7M Hold
2,472,327
– – 0.9% 37
2022
Q2 		$17.7M Hold
2,472,327
– – 0.85% 36
2022
Q1 		$26.5M Buy
2,472,327
+598,995
+32% +$7.11M 1.06% 31
2021
Q4 		$26.4M Buy
1,873,332
+178,399
+11% +$3.54M 0.96% 29
2021
Q3 		$29.8M Buy
+1,694,933
New +$32.4M 1.16% 23

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $151M AUM 296.21% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

BVF Inc's TYRA Position: Q1 2026 in Review

BVF Inc reduced its Tyra Biosciences (TYRA) stake by 7.1% in Q1 2026, selling an estimated $4.9M and leaving 1,976,196 shares worth $75.7M. The position accounts for 2.41% of the portfolio, ranked #16.

BVF Inc first reported a position in TYRA in Q3 2021 and has held it in 19 quarters since. The position peaked at $110M in Q3 2024. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

  • BVF Inc held 1,976,196 shares of Tyra Biosciences worth $75.7M as of Q1 2026.
  • BVF Inc sold 151,469 Tyra Biosciences shares in Q1 2026, an estimated $4.9M.
  • Tyra Biosciences made up 2.41% of BVF Inc's portfolio in Q1 2026, its #16 holding.
  • BVF Inc first reported a position in Tyra Biosciences in Q3 2021 and has held it in 19 quarters since.
  • BVF Inc's Tyra Biosciences position peaked at $110M in Q3 2024.
  • 164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on BVF Inc's 13F filing for Q1 2026, filed 15 May 2026.